3rd Quarter - Report

HALEON US HOLDINGS LLC for HALEON US HOLDINGS LLC

Firm
Client
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

20 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General monitoring of legislative and administrative action related to Medicare and Medicaid policy, including changes in coverage/eligibility. General monitoring of Medicare coverage of dental services; General review of legislation, rulemaking impacting dual eligible enrollees

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Agriculture AGR

General review and monitoring of farm bill legislation, particularly provisions related to nutrition. Monitor on legislative and administrative action related to White House Conference on Hunger; H.R.3087 - Training and Nutrition Stability; S.2131 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3087 (118th), S. 2131 (118th)

Family issues/Abortion/Adoption FAM

General review of federal policies applying towards paid family and medical leave. General review of legislative and administration action related to pediatric over-the-counter concerns.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process; and Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

General review and monitoring of legislative and administrative actions on banning noncompete clauses; Modernization of Cosmetics Regulation Act of 2022 (MoCRA) implementation; and General review and monitoring of legislative and administrative actions related to the design, development, and deployment of artificial intelligence platforms, especially as related to healthcare and protection of personally identifiable information.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

General monitoring of legislative and administrative action related to intellectual property protection.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

Preventing youth consumption of tobacco products; Smoking cessation and over-the-counter alternatives for adult consumers; and General review of legislation and administrative action allowing for original Medicare and Part D coverage of over-the-counter smoking cessation products.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Manufacturing MAN

General issues related to the manufacturing and supply chain resiliency of over-the-counter medications; and H.R. 3622 Cosmetic Supply Chain Transparency Act. General review and monitoring of Modernization of Cosmetics Regulation Act of 2022 implementation. Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3622 (118th)

Health Issues HCR

General monitoring of legislative and administrative action related to health care policy; General monitoring of legislative and administrative action related to womens health issues; General monitoring of legislative and administrative action related to over-the-counter consumer healthcare products; General monitoring of legislative and administrative action related to dietary supplements, multivitamin, and hunger issues; General monitoring of legislative and administrative action related to servicing of medical device equipment; General monitoring of legislative and administrative action related to the Supplemental Nutrition Assistance Program (SNAP); General monitoring of legislative and administrative action related to FDA monograph reform and user fees; General monitoring of legislative and administrative action related to the switch of prescription medications to over-the-counter medications; Review of issues related to Prescription Drug User Fee Act Reauthorization (PDUFA); Review of coverage for medically necessary services in Medicare and Medicare Advantage, including dental coverage, to address underlying conditions in advance of major surgery; General review and monitoring of processes impacting over-the-counter switches, including Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) rulemaking process Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation. General monitoring of issues related to the reauthorization of "Pandemic and All-Hazards Preparedness Act" PAHPA Defense Production Act (DPA) issues, specifically on manufacturing impacts on over-the-counter medications. S. 818 Maximizing Opioid Recovery Emergency Savings Act, in particular, provisions related to drugs and biologicals; Review of legislation impacting the Dietary Supplement Health and Education Act of 1994, in particular, provisions related to Mandatory Product Listing (MPL); and S. 923, Better Mental Health Care for Americans Act, specifically provisions related to substance use disorders. H.R. 831 Medicare Medically Necessary Dental Care Act of 2023

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 831 (118th), S. 818 (118th), S. 923 (118th)

Labor Issues/Antitrust/Workplace LBR

General review of federal policies applying towards paid family and medical leave.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Implementation of H.R. 5376, Inflation Reduction Act of 2022; FY 2024 Appropriations for NIH, NCI, CDC, FDA, and related preventive healthcare accounts; FY2024 Labor, Health and Human Services, Education and Related Agencies (LHHS-ED) Appropriations; H.R.4394 - Energy and Water Development and Related Agencies Appropriations Act, 2024; H.R.4368 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024; and H.R. 4365 Department of Defense Appropriations Act, 2024 S.2131 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 S.2443 - Energy and Water Development and Related Agencies Appropriations Act, 2024

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (118th), H.R. 4394 (118th), S. 2443 (118th), S. 2131 (118th), H.R. 4365 (118th), S. 2624 (118th), H.R. 4368 (118th)

Civil Rights/Civil Liberties CIV

General review and monitoring of legislative and administrative actions related to societal issues or justice; and General health inclusivity issues;

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

H.R. 2670 National Defense Authorization Act for Fiscal Year 2024 S.2587 - Department of Defense Appropriations Act, 2024 H.R.4365 - Department of Defense Appropriations Act, 2024

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2670 (118th), H.R. 4365 (118th), S. 2587 (118th)

Taxation/Internal Revenue Code TAX

Implementation of H.R. 3684, Infrastructure Investment and Jobs Act; General monitoring of Issues related to federal tax amortization of research and development expenses; General review and monitoring of legislation that includes over-the-counter dietary supplement products, specifically multivitamins, as qualified medical expenses; General review and monitoring of legislation and administrative action related to oral healthcare products, including specialty toothpastes and rinses, as qualified medical expenses under HSA/FSA

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3684 (118th)

Trade (domestic/foreign) TRD

General international trade policy related to tariffs, import, export concerns. General monitoring of legislative and administrative action related to foreign regulation of chemicals, ingredients, and health care products. General monitoring of legislative and administrative action related to implementation of the United States-Mexico-Canada Agreement (USMCA) WTO Covid TRIPS waiver proposal General review and monitoring of supply chain concerns, including impact of Russian invasion of Ukraine.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Food Industry (safety, labeling, etc.) FOO

Multivitamin and nutrition issues. Review of legislative or administrative action related to melatonin, specifically gummy products on products labeled for adult use; and S Res 35 Resolution designating October 22 through October 28, 2023, as "Natural Product Industry Week"

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Res. 35 (118th)

Environment/Superfund ENV

General monitoring of legislative and administrative action related to climate change; and General monitoring of legislative and administrative action related to sustainability, particularly related to packaging and consumables. General monitoring and review of legislative and administration actions related to water consumption, particularly initiatives aimed at reducing water use or increasing savings; and H.R. 2964/S.1350 Wastewater Infrastructure Pollution Prevention and Environmental Safety Act/WIPPES Act

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2964 (118th), S. 1350 (118th)

Government Issues GOV

General review of FDA rulemaking and processes on cannabis, specifically CBD, and associated proposed safety standards for CBD to be lawfully marketed as a dietary supplement or food additive. Monitor and engage on legislative and administrative action related to phenylephrine and pseudoephedrine regulation.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Energy/Nuclear ENG

General review and monitoring of renewable energy legislation and regulations.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

General review and monitoring of U.S. diplomatic relations.

LobbyistCovered position, as disclosed
ELIZABETH BREWER —
JONATHAN MARTINEZ —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.